|
Corporate Presentation |
|
Efficacy of Seladelpar for Amelioration of Fibrosis and NASH in a Diet-Induced and Biopsy- Confirmed Mouse Model: Comparison to Liraglutide, Selonsertib and Obeticholic Acid |
|
Combination Therapy of Seladelpar and Liraglutide Attenuates Obesity, Hepatic Steatosis and Fibrosis in a Diet Mouse Model of NASH |
|
Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, Randomized, Dose-Ranging Phase 2 Study |
|
Efficacy and Safety of Seladelpar in Primary Biliary Cholangitis 52-Week Analysis of a Dose-Ranging Phase 2 Study |
